Sawai Acquires Sumitomo Stake In Generic Joint Venture
This article was originally published in PharmAsia News
Executive Summary
Sawai Pharmaceutical acquired Sumitomo Shoji's 30 percent stake in Medisa Shinyaku June 18, making the generic drug maker a Sawai wholly owned subsidiary